Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

Effects of environmental and anthropogenic landscape features on mule deer harvest in Nebraska.

O'Connor BJ, Fryda NJ, Ranglack DH.

PeerJ. 2018 Sep 10;6:e5510. doi: 10.7717/peerj.5510. eCollection 2018.

2.

Bronchoabsorption; a novel bronchoscopic technique to improve biomarker sampling of the airway.

Leaker BR, Nicholson GC, Ali FY, Daudi N, O'Connor BJ, Barnes PJ.

Respir Res. 2015 Sep 4;16:102. doi: 10.1186/s12931-015-0268-5.

3.

The effects of the novel SHIP1 activator AQX-1125 on allergen-induced responses in mild-to-moderate asthma.

Leaker BR, Barnes PJ, O'Connor BJ, Ali FY, Tam P, Neville J, Mackenzie LF, MacRury T.

Clin Exp Allergy. 2014 Sep;44(9):1146-53. doi: 10.1111/cea.12370.

PMID:
25040039
4.

Setipiprant, a selective CRTH2 antagonist, reduces allergen-induced airway responses in allergic asthmatics.

Diamant Z, Sidharta PN, Singh D, O'Connor BJ, Zuiker R, Leaker BR, Silkey M, Dingemanse J.

Clin Exp Allergy. 2014 Aug;44(8):1044-52. doi: 10.1111/cea.12357.

PMID:
24964348
5.

The 5-lipoxygenase-activating protein inhibitor, GSK2190915, attenuates the early and late responses to inhaled allergen in mild asthma.

Kent SE, Boyce M, Diamant Z, Singh D, O'Connor BJ, Saggu PS, Norris V.

Clin Exp Allergy. 2013 Feb;43(2):177-86. doi: 10.1111/cea.12002.

PMID:
23331559
6.

Rapid effects of extrafine beclomethasone dipropionate/formoterol fixed combination inhaler on airway inflammation and bronchoconstriction in asthma: a randomised controlled trial.

O'Connor BJ, Collarini S, Poli G, Brindicci C, Spinola M, Acerbi D, Barnes PJ, Leaker B.

BMC Pulm Med. 2011 Dec 21;11:60. doi: 10.1186/1471-2466-11-60.

7.

Efficacy and safety of ciclesonide in patients with severe asthma: a 12-week, double-blind, randomized, parallel-group study with long-term (1-year) follow-up.

O'Connor BJ, Kilfeather S, Cheung D, Kafé H, Blagden MD, Schlösser N, Ayres JG, Weber HJ, Engelstätter R.

Expert Opin Pharmacother. 2010 Dec;11(17):2791-803. doi: 10.1517/14656566.2010.526603. Epub 2010 Oct 19.

PMID:
20958119
8.

Programmatic research in medical education: a national collaboration.

Wilkinson TJ, Weller JM, McKimm J, O'Connor BJ, Pinnock RE, Poole PJ, Sheehan D, Tweed MJ, Wearn AM.

N Z Med J. 2010 Jul 16;123(1318):24-33.

PMID:
20651864
9.

A novel technique to explore the functions of bronchial mucosal T cells in chronic obstructive pulmonary disease: application to cytotoxicity and cytokine immunoreactivity.

Lethbridge MW, Kemeny DM, Ratoff JC, O'Connor BJ, Hawrylowicz CM, Corrigan CJ.

Clin Exp Immunol. 2010 Sep;161(3):560-9. doi: 10.1111/j.1365-2249.2010.04198.x.

10.

Setting up new learning environments in regional and rural areas.

Bagg W, Dare AJ, O'Connor BJ, Poole P, Reid JJ, Rudland J, Tweed MJ, Wilkinson TJ.

N Z Med J. 2010 Apr 9;123(1312):83-90.

PMID:
20389324
11.

The inhaled phosphodiesterase 4 inhibitor GSK256066 reduces allergen challenge responses in asthma.

Singh D, Petavy F, Macdonald AJ, Lazaar AL, O'Connor BJ.

Respir Res. 2010 Mar 1;11:26. doi: 10.1186/1465-9921-11-26.

12.

Diminished sarco/endoplasmic reticulum Ca2+ ATPase (SERCA) expression contributes to airway remodelling in bronchial asthma.

Mahn K, Hirst SJ, Ying S, Holt MR, Lavender P, Ojo OO, Siew L, Simcock DE, McVicker CG, Kanabar V, Snetkov VA, O'Connor BJ, Karner C, Cousins DJ, Macedo P, Chung KF, Corrigan CJ, Ward JP, Lee TH.

Proc Natl Acad Sci U S A. 2009 Jun 30;106(26):10775-80. doi: 10.1073/pnas.0902295106. Epub 2009 Jun 16.

13.

Induction of angiogenesis by airway smooth muscle from patients with asthma.

Simcock DE, Kanabar V, Clarke GW, Mahn K, Karner C, O'Connor BJ, Lee TH, Hirst SJ.

Am J Respir Crit Care Med. 2008 Sep 1;178(5):460-8. doi: 10.1164/rccm.200707-1046OC. Epub 2008 Jun 12.

PMID:
18556625
14.

Heparin and structurally related polymers attenuate eotaxin-1 (CCL11) release from human airway smooth muscle.

Kanabar V, Page CP, Simcock DE, Karner C, Mahn K, O'Connor BJ, Hirst SJ.

Br J Pharmacol. 2008 Jun;154(4):833-42. doi: 10.1038/bjp.2008.109. Epub 2008 Apr 21.

15.

Superiority of "triple" therapy with salmeterol/fluticasone propionate and tiotropium bromide versus individual components in moderate to severe COPD.

Singh D, Brooks J, Hagan G, Cahn A, O'Connor BJ.

Thorax. 2008 Jul;63(7):592-8. doi: 10.1136/thx.2007.087213. Epub 2008 Feb 1.

PMID:
18245142
16.

Elevated expression of adenosine A1 receptor in bronchial biopsy specimens from asthmatic subjects.

Brown RA, Clarke GW, Ledbetter CL, Hurle MJ, Denyer JC, Simcock DE, Coote JE, Savage TJ, Murdoch RD, Page CP, Spina D, O'Connor BJ.

Eur Respir J. 2008 Feb;31(2):311-9. Epub 2007 Oct 24.

17.

Selective inducible nitric oxide synthase inhibition has no effect on allergen challenge in asthma.

Singh D, Richards D, Knowles RG, Schwartz S, Woodcock A, Langley S, O'Connor BJ.

Am J Respir Crit Care Med. 2007 Nov 15;176(10):988-93. Epub 2007 Aug 23.

PMID:
17717202
18.

The safety and effects of the beta-blocker, nadolol, in mild asthma: an open-label pilot study.

Hanania NA, Singh S, El-Wali R, Flashner M, Franklin AE, Garner WJ, Dickey BF, Parra S, Ruoss S, Shardonofsky F, O'Connor BJ, Page C, Bond RA.

Pulm Pharmacol Ther. 2008;21(1):134-41. Epub 2007 Jul 17.

19.

Proangiogenic activity in bronchoalveolar lavage fluid from patients with asthma.

Simcock DE, Kanabar V, Clarke GW, O'Connor BJ, Lee TH, Hirst SJ.

Am J Respir Crit Care Med. 2007 Jul 15;176(2):146-53. Epub 2007 Apr 26.

PMID:
17463417
20.

Cold air and exercise challenge -- influence of minute ventilation.

Sylvester KP, O'Connor BJ, Farebrother HM, Rafferty GF, Greenough A.

J Asthma. 2007 Mar;44(2):143-7.

PMID:
17454330
21.

Zileuton added to low-dose inhaled beclomethasone for the treatment of moderate to severe persistent asthma.

O'Connor BJ, Löfdahl CG, Balter M, Szczeklik A, Boulet LP, Cairns CB.

Respir Med. 2007 Jun;101(6):1088-96. Epub 2007 Mar 13.

22.

Class switch recombination to IgE in the bronchial mucosa of atopic and nonatopic patients with asthma.

Takhar P, Corrigan CJ, Smurthwaite L, O'Connor BJ, Durham SR, Lee TH, Gould HJ.

J Allergy Clin Immunol. 2007 Jan;119(1):213-8.

PMID:
17208604
23.

Laceration of the popliteal artery and compartment syndrome resulting from stingray envenomation.

Derr C, O'Connor BJ, Macleod SL.

Am J Emerg Med. 2007 Jan;25(1):96-7. No abstract available.

PMID:
17157695
24.

Lack of neutrophil degranulation in low-dose endotoxin inhalation based on a novel intracellular assay.

Loh LC, Lo WH, Kanabar V, O'Connor BJ.

Asian Pac J Allergy Immunol. 2006 Jun-Sep;24(2-3):153-60.

25.

Systemic glucocorticoid reduces bronchial mucosal activation of activator protein 1 components in glucocorticoid-sensitive but not glucocorticoid-resistant asthmatic patients.

Loke TK, Mallett KH, Ratoff J, O'Connor BJ, Ying S, Meng Q, Soh C, Lee TH, Corrigan CJ.

J Allergy Clin Immunol. 2006 Aug;118(2):368-75. Epub 2006 Jun 27.

PMID:
16890760
26.

Extracellular matrix regulates enhanced eotaxin expression in asthmatic airway smooth muscle cells.

Chan V, Burgess JK, Ratoff JC, O'connor BJ, Greenough A, Lee TH, Hirst SJ.

Am J Respir Crit Care Med. 2006 Aug 15;174(4):379-85. Epub 2006 May 18.

PMID:
16709936
27.

Sputum induction in corticosteroid-dependant asthmatics: risks and airway cellular profile.

Loh LC, Kanabar V, D'Amato M, Barnes NC, O'Connor BJ.

Asian Pac J Allergy Immunol. 2005 Dec;23(4):189-96.

28.

Phosphodiesterase (PDE) 7 in inflammatory cells from patients with asthma and COPD.

Jones NA, Leport M, Holand T, Vos T, Morgan M, Fink M, Pruniaux MP, Berthelier C, O'Connor BJ, Bertrand C, Page CP.

Pulm Pharmacol Ther. 2007;20(1):60-8. Epub 2006 Jan 20.

PMID:
16427796
29.

Bronchoprotection with formoterol via dry powder and metered-dose inhalers in patients with asthma.

Lipworth BJ, Sims EJ, Das SK, Morice AH, O'Connor BJ.

Ann Allergy Asthma Immunol. 2005 Sep;95(3):283-90.

PMID:
16200820
30.

Gelsolin secretion in interleukin-4-treated bronchial epithelia and in asthmatic airways.

Candiano G, Bruschi M, Pedemonte N, Caci E, Liberatori S, Bini L, Pellegrini C, Viganò M, O'Connor BJ, Lee TH, Galietta LJ, Zegarra-Moran O.

Am J Respir Crit Care Med. 2005 Nov 1;172(9):1090-6. Epub 2005 Aug 11.

PMID:
16100010
31.

Inhaled endotoxin in healthy human subjects: a dose-related study on systemic effects and peripheral CD4+ and CD8+ T cells.

Loh LC, Vyas B, Kanabar V, Kemeny DM, O'Connor BJ.

Respir Med. 2006 Mar;100(3):519-28. Epub 2005 Jul 20.

32.
33.

Expression of prostaglandin E(2) receptor subtypes on cells in sputum from patients with asthma and controls: effect of allergen inhalational challenge.

Ying S, O'Connor BJ, Meng Q, Woodman N, Greenaway S, Wong H, Mallett K, Lee TH, Corrigan C.

J Allergy Clin Immunol. 2004 Dec;114(6):1309-16.

PMID:
15577828
34.

The ideal inhaler: design and characteristics to improve outcomes.

O'Connor BJ.

Respir Med. 2004 Apr;98 Suppl A:S10-6.

35.

Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma: a pilot study.

Kips JC, O'Connor BJ, Langley SJ, Woodcock A, Kerstjens HA, Postma DS, Danzig M, Cuss F, Pauwels RA.

Am J Respir Crit Care Med. 2003 Jun 15;167(12):1655-9. Epub 2003 Mar 20.

PMID:
12649124
36.

Pharmacokinetic and pharmacodynamic profile following oral administration of the phosphodiesterase (PDE)4 inhibitor V11294A in healthy volunteers.

Gale DD, Landells LJ, Spina D, Miller AJ, Smith K, Nichols T, Rotshteyn Y, Tonelli A, Lacouture P, Burch RM, Page CP, O'Connor BJ.

Br J Clin Pharmacol. 2002 Nov;54(5):478-84.

37.

Rapid effect of inhaled fluticasone propionate on airway responsiveness to adenosine 5'-monophosphate in mild asthma.

Ketchell RI, Jensen MW, Lumley P, Wright AM, Allenby MI, O'connor BJ.

J Allergy Clin Immunol. 2002 Oct;110(4):603-6.

PMID:
12373268
38.
39.

Dose-related effects of formoterol on airway responsiveness to adenosine 5'-monophosphate and histamine.

Ketchell RI, Jensen MW, Spina D, O'Connor BJ.

Eur Respir J. 2002 Apr;19(4):611-6.

40.

Identification and quantification of phosphodiesterase 4 subtypes in CD4 and CD8 lymphocytes from healthy and asthmatic subjects.

Landells LJ, Szilagy CM, Jones NA, Banner KH, Allen JM, Doherty A, O'Connor BJ, Spina D, Page CP.

Br J Pharmacol. 2001 Jul;133(5):722-9.

41.

Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response.

Bryan SA, O'Connor BJ, Matti S, Leckie MJ, Kanabar V, Khan J, Warrington SJ, Renzetti L, Rames A, Bock JA, Boyce MJ, Hansel TT, Holgate ST, Barnes PJ.

Lancet. 2000 Dec 23-30;356(9248):2149-53.

PMID:
11191543
42.

Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response.

Leckie MJ, ten Brinke A, Khan J, Diamant Z, O'Connor BJ, Walls CM, Mathur AK, Cowley HC, Chung KF, Djukanovic R, Hansel TT, Holgate ST, Sterk PJ, Barnes PJ.

Lancet. 2000 Dec 23-30;356(9248):2144-8.

PMID:
11191542
43.

Hyperventilation and asymptomatic chronic asthma.

Osborne CA, O'Connor BJ, Lewis A, Kanabar V, Gardner WN.

Thorax. 2000 Dec;55(12):1016-22.

44.

A biochemical and functional assessment of monocyte phosphodiesterase activity in healthy and asthmatic subjects.

Landells LJ, Spina D, Souness JE, O'Connor BJ, Page CP.

Pulm Pharmacol Ther. 2000;13(5):231-9.

PMID:
11003567
45.

The role of adenosine receptors in the action of theophylline on human peripheral blood mononuclear cells from healthy and asthmatic subjects.

Landells LJ, Jensen MW, Orr LM, Spina D, O'Connor BJ, Page CP.

Br J Pharmacol. 2000 Mar;129(6):1140-4.

46.

A long-term study of the antiinflammatory effect of low-dose budesonide plus formoterol versus high-dose budesonide in asthma.

Kips JC, O'Connor BJ, Inman MD, Svensson K, Pauwels RA, O'Byrne PM.

Am J Respir Crit Care Med. 2000 Mar;161(3 Pt 1):996-1001.

PMID:
10712354
47.

Comparison of incremental and bolus dose inhaled allergen challenge in asthmatic patients.

Taylor DA, Harris JG, O'Connor BJ.

Clin Exp Allergy. 2000 Jan;30(1):56-63.

PMID:
10606931
48.

CD8(+) T cell subsets and chronic obstructive pulmonary disease.

Kemeny DM, Vyas B, Vukmanovic-Stejic M, Thomas MJ, Noble A, Loh LC, O'Connor BJ.

Am J Respir Crit Care Med. 1999 Nov;160(5 Pt 2):S33-7. Review.

PMID:
10556167
49.

Expression and activation of protein kinase C-zeta in eosinophils after allergen challenge.

Evans DJ, Lindsay MA, Webb BL, Kankaanranta H, Giembycz MA, O'Connor BJ, Barnes PJ.

Am J Physiol. 1999 Aug;277(2):L233-9. doi: 10.1152/ajplung.1999.277.2.L233.

PMID:
10444516
50.

A dose-dependent effect of the novel inhaled corticosteroid ciclesonide on airway responsiveness to adenosine-5'-monophosphate in asthmatic patients.

Taylor DA, Jensen MW, Kanabar V, Engelstätter R, Steinijans VW, Barnes PJ, O'Connor BJ.

Am J Respir Crit Care Med. 1999 Jul;160(1):237-43.

PMID:
10390406

Supplemental Content

Loading ...
Support Center